
Dan Ives initiated coverage of SpaceX (NASDAQ: SPCX) with an Outperform rating and a $190 price target, implying ~17.3% upside over the next 12 months; he highlighted Starlink as the profit engine (2025 operating profit of $4.4B and adjusted EBITDA of nearly $7.2B). However, the bull case is heavily dependent on Starship, which has completed 12 test flights but is not yet operating as designed and could face regulatory pressure, while the company’s orbital AI compute satellite timeline (as early as 2028) appears aggressive versus execution risk. Net: despite a solid target, the article flags an unfavorable risk-reward given SpaceX’s high valuation and uncertainty around Starship-driven orbital data centers.
The market is effectively capitalizing a multi-year option chain as if the end state were already visible. That leaves the stock vulnerable to a valuation reset if execution slips: the near-term cash engine can support the business, but the incremental value is coming from a path-dependent technology stack that still needs regulatory, manufacturing, and launch reliability proof. In other words, the downside is not from today’s revenue; it is from the market realizing the terminal value math is too front-loaded. The key second-order effect is on capital allocation across the AI infrastructure complex. If this asset trades rich on the promise of cheaper/faster compute deployment, it raises the bar for public peers in AI infrastructure to show contracted, non-cancelable demand rather than narrative-driven bookings. The weak point is customer optionality: short-notice cancellation rights mean headline deals are not the same as durable backlog, so any slowdown in conversion should hit sentiment before it hits reported numbers. Near term, the catalyst path is binary around technical milestones and any regulatory friction; over 1-3 months, a failed test or delay should compress the speculative premium quickly. Over 6-18 months, the thesis only works if the current cash engine can keep compounding while the moonshot remains funded without diluting returns. The contrarian view is that the name may be less cheap than it looks because the market is already paying for a best-case timeline, not just a best-case outcome.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment